APA (7th ed.) Citation

U, J., J, K., RJ, H., G, N., LM, T. H., JA, M., . . . JM, D. (2009). Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: The Hoorn Study. European Journal of Clinical Nutrition, 63(1), 150. https://doi.org/10.1038/sj.ejcn.1602964

Chicago Style (17th ed.) Citation

U, Jaakkola, Kallio J, Heine RJ, Nijpels G, T' Hart LM, Maassen JA, Bouter LM, Stehouwer CD, and Dekker JM. "Neuropeptide Y Polymorphism Significantly Magnifies Diabetes and Cardiovascular Disease Risk in Obesity: The Hoorn Study." European Journal of Clinical Nutrition 63, no. 1 (2009): 150. https://doi.org/10.1038/sj.ejcn.1602964.

MLA (9th ed.) Citation

U, Jaakkola, et al. "Neuropeptide Y Polymorphism Significantly Magnifies Diabetes and Cardiovascular Disease Risk in Obesity: The Hoorn Study." European Journal of Clinical Nutrition, vol. 63, no. 1, 2009, p. 150, https://doi.org/10.1038/sj.ejcn.1602964.